Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision label updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a new deployment of the page. This change represents an internal version update rather than a modification to study content.
    Difference
    0.0%
    Check dated 2026-07-04T03:52:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new site revision tag (v3.6.2) has been introduced, replacing the previous revision (v3.6.0). This indicates a minor platform update without altering the study details or primary content.
    Difference
    0.0%
    Check dated 2026-06-27T00:09:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added new help/navigation items (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment section label, along with a site Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T15:32:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page’s footer revision tag was updated to v3.5.5, signaling a minor page revision. This change typically reflects small content or formatting updates rather than alterations to study data.
    Difference
    0.0%
    Check dated 2026-06-05T09:54:12.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The locations section has been expanded to add new recruitment sites, bringing the total to 21 locations across multiple states. New sites include Virginia Mason Medical Center in Seattle, WA, along with several other participating centers.
    Difference
    1%
    Check dated 2026-05-22T09:17:07.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A new NEJM publication citation for Daraxonrasib in previously treated advanced RAS-mutant pancreatic cancer has been added, and the page revision tag was updated from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-15T03:30:19.000Z thumbnail image

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.